mitoxantrone has been researched along with Dermatitis Medicamentosa in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Usually, thrombocytopenia was not associated with bleeding manifestations." | 2.45 | Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. ( Ben-Bassat, I; Bonstein, L; Gafter-Gvili, A; Raanani, P; Ram, R; Shpilberg, O, 2009) |
| "More recently, a number of cases of panniculitis and subcutaneous inflammatory oedema have been described." | 1.37 | [Severe skin reaction with mucous membrane inflammation during MINE chemotherapy]. ( Camus, M; Guillet, G; Hainaut-Wierzbicka, E; Levillain, P; Lopez, L; Saulnier, JP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ram, R | 1 |
| Bonstein, L | 1 |
| Gafter-Gvili, A | 1 |
| Ben-Bassat, I | 1 |
| Shpilberg, O | 1 |
| Raanani, P | 1 |
| Camus, M | 1 |
| Hainaut-Wierzbicka, E | 1 |
| Levillain, P | 1 |
| Saulnier, JP | 1 |
| Lopez, L | 1 |
| Guillet, G | 1 |
| Awan, F | 1 |
| Hamadani, M | 1 |
| Devine, S | 1 |
| Sternberg, DW | 1 |
| Aird, W | 1 |
| Neuberg, D | 1 |
| Thompson, L | 1 |
| MacNeill, K | 1 |
| Amrein, P | 1 |
| Shulman, LN | 1 |
| Kerr, IG | 1 |
| Deangelis, C | 1 |
| Assaad, DM | 1 |
| Hanna, SS | 1 |
1 review available for mitoxantrone and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2009 |
4 other studies available for mitoxantrone and Dermatitis Medicamentosa
| Article | Year |
|---|---|
[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Edema; Etoposide; Female | 2011 |
Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Eruptions; | 2007 |
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Com | 2000 |
Drug extravasation along the route of a peritoneal catheter during intraperitoneal chemotherapy.
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Catheters, Indwe | 1987 |